According to the Journal Citation Reports, the journal had a 2016 impact factor of 1.937 and 18,614 total cites. Cancer Genomics & Proteomics: January-February, 2009.
Anticancer Research Impact Factor, IF, number of article, detailed information and journal factor. If you have any questions about the journals, please contact: International Institute of Anticancer Research (IIAR), ANTICANCER RESEARCH, IN VIVO and CANCER GENOMICS & PROTEOMICS 1 Fax:+30-22950-52945 ext.
Anticancer Research was established in 1981 by J. G. Delinasios. Cancer Genomics & Proteomics supports (a) the aims and the research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH. Questions regarding difficulties in using the online submission system should be addressed to: journals@iiar-anticancer.org, Copyright © 2020 by The International Institute of Anticancer Research, Alert me to new issues of Anticancer Research, The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research, Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol, Biological Effects of Sunlight, Ultraviolet Radiation, Visible Light, Infrared Radiation and Vitamin D for Health, Periapical Cemento-osseous Dysplasia: Clinicopathological Features, Anticancer Properties of Capsaicin Against Human Cancer, Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies, The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic
Established: For more information about IIAR and the journals please visit our website www.iiar-anticancer.org. Anticancer Research was established in 1981 by J. G. Delinasios. 1st km Kapandritiou-Kalamou Road, P.O. January 2004 - September-October 2020. The International Institute of Anticancer Research (IIAR) and Stanford University's HighWire Press are delighted to announce ANTICANCER RESEARCH (AR) will accept original high quality works and reviews on all aspects of experimental and clinical cancer research.
Impact factor (2020): 3.28 Publication Data Manuscripts must be submitted only through our online submission system at: http://www.iiar-submissions.com/login.html.
Tools of interest to librarians include: Anticancer Research (http://ar.iiarjournals.org) is an international peer-reviewed journal designed to publish rapidly original papers and reviews on all aspects of experimental Box 22, GR-19014 Kapandriti, Attiki, Greece USA Branch: Anticancer Research USA, Inc., P.O.B. In Vivo (http://iv.iiarjournals.org) is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental CGP was established in 2004. Questions regarding difficulties in using the online submission system should be addressed to: email: journals@iiar-anticancer.org.
options and browsing capabilities, linking tools, email alerts and RSS feeds.
Articles in Anticancer Research are regularly indexed in all bibliographic services. their new partnership for online publishing of the three IIAR journals - ANTICANCER RESEARCH, IN VIVO and CANCER GENOMICS Impact Factor 2018 di Anticancer Research è 1.935 (Ultimi dati nel 2019).
2004.
and clinical biomedical research within the frame of comparative physiology-pathology and drug research. Established: 1987. 280, Belmar, NJ 07719, USA Tel: +30-22950-52945 ext. Please follow the Instructions for Authors regarding the format of your manuscript and references. Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of Anticancer Research is 100.0%. Established: 1981.
& PROTEOMICS.
280, Belmar, NJ 07719, USA Variation in Age-adjusted Cancer Mortality Rates, Epithelial-Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma, Tumor-specificity and Type of Cell Death Induced by Trihaloacetylazulenes in Human Tumor Cell Lines, Stressful and Adverse Life Experiences in Patients with Breast Symptoms; a Prospective Case-control Study in Kuopio, Finland. The impact factor (IF) 2018 of Anticancer Research is 1.94, which is computed in 2019 as per it's definition.Anticancer Research IF is increased by a factor of 0.02 and approximate percentage change is 1.04% when compared to preceding year 2017, which shows a rising trend.
According to the Journal Citation Reports , the journal had a 2016 impact factor of 1.937 and 18,614 total cites. reviews on the application of genomic and proteomic technology to experimental and clinical cancer research. Box 22, GR-19014 Kapandriti, Attiki, Greece, USA Branch: Anticancer Research USA, Inc., P.O.B. The definition of journal acceptance rate is the percentage of all articles submitted to Anticancer Research that was accepted for publication. Anticancer Research.
Established: 1981. Cancer Genomics & Proteomics (http://cgp.iiarjournals.org) is an online-only open access international peer-reviewed journal designed to publish rapidly high quality articles and